<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 58-year-old male was diagnosed as having <z:e sem="disease" ids="C0856536" disease_type="Neoplastic Process" abbrv="">Philadelphia chromosome-positive</z:e> <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> and treated with <z:chebi fb="0" ids="45783">imatinib</z:chebi> combined chemotherapy followed by reduced-intensity cord blood transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>After transplantation, the graft was rejected but the Philadelphia-positive <z:hpo ids='HP_0001909'>leukemia</z:hpo> clone was eliminated </plain></SENT>
<SENT sid="2" pm="."><plain>Following graft rejection, hematopoietic recovery with del (20q) gradually occurred </plain></SENT>
<SENT sid="3" pm="."><plain>These findings suggest that this patient had transformed to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> from <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> with del (20q) after acquisition of the Philadelphia chromosome </plain></SENT>
</text></document>